InVivoMab anti-mouse OX40L (CD134L)

Catalog number: BE0033-1_50mg
Brand: Bio X Cell
Packing: 50 mg
Other sizes: 1 mg
5 mg
25 mg
100 mg
Price: € 1836.00
Expected delivery time: 7 days
Quantity:

Product specifications for - InVivoMab anti-mouse OX40L (CD134L)

Promotion: 
Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Overview: 
Product group: Antibodies
Category: Primary Antibodies
Application: Neutralisation/Blocking
Species: Mouse
Host: Rat
Clonality: Monoclonal
Isotype: IgG2b Kappa
Properties: 
Molecular weight: 150 kDa
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 2-10 mg/ml
Scientific information: 
Clone ID: RM134L
Related products: 
Related products: Recommended Isotype Control(s): InVivoMab rat IgG2b isotype control (BE0090)
Recommended Dilution Buffer: InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information: 
Synonyms: RM134L; BE0033-1; OX40 Ligand / OX40L; TNFSF4; TXGP1; OX4OL; OX-40L; GP34; CD252; CD134L; tumor necrosis factor ligand superfamily member 4; tax-transcriptionally activated glycoprotein 1 (34kD); glycoprotein Gp34; TAX transcriptionally-activated glycoprotein 1; OX40L; OX40 antigen ligand; CD134 ligand; tumor necrosis factor (ligand) superfamily, member 4; BioXCell
Gattringer M, Baranyi U, Pilat N, et al. Anti-OX40L alone or in combination with anti-CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen. Clin Exp Allergy. 2016;46(2):354-64. Read more
Welten SP, Redeker A, Franken KL, et al. The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion. Elife. 2015;4 Read more
Baeyens A, Saadoun D, Billiard F, et al. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context. J Immunol. 2015;194(3):999-1010. Read more
Xin L, Jiang TT, Chaturvedi V, et al. Commensal microbes drive intestinal inflammation by IL-17-producing CD4+ T cells through ICOSL and OX40L costimulation in the absence of B7-1 and B7-2. Proc Natl Acad Sci USA. 2014;111(29):10672-7. Read more
Mahmud SA, Manlove LS, Schmitz HM, et al. Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat Immunol. 2014;15(5):473-81. Read more
Leyva-castillo JM, Hener P, Michea P, et al. Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade. Nat Commun. 2013;4:2847. Read more
Hong J, Yeom HJ, Lee E, et al. Islet allograft rejection in sensitized mice is refractory to control by combination therapy of immune-modulating agents. Transpl Immunol. 2013;28(2-3):86-92. Read more
Kurche JS, Burchill MA, Sanchez PJ, Haluszczak C, Kedl RM. Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses. J Immunol. 2010;185(4):2106-15. Read more